- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02555579
Simplified Diet Approach in Phenylketonuria
Use of Dietary Protein and Free Fruits and Vegetables to Improve Metabolic Control Among Teens and Adults With Phenylketonuria: A Mixed Methods Approach
This is a study to determine if a simplified protein counting system, including the free usage of fruits and vegetables low in phenylalanine, will improve the metabolic control in teens and adults with phenylketonuria (PKU).
Anybody with a positive diagnosis of PKU, between the ages of 13-65 years will be invited to participate in this study.
Subjects will be educated on the simplified system upon enrollment, and historical phenylalanine (Phe) levels will be used for comparison. Subjects will also be asked about their attitudes towards their current Phe counting system.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a study to determine if a simplified protein counting system, including the free usage of fruits and vegetables low in phenylalanine, will improve the metabolic control in teens and adults with phenylketonuria (PKU).
Anybody with a positive diagnosis of PKU, between the ages of 13-65 years will be invited to participate in this study.
Subjects will be educated on the simplified system upon enrollment, and historical phenylalanine (Phe) levels will be used for comparison. Subjects will also be asked about their attitudes towards their current Phe counting system.
Upon enrollment, a 3-day food record and Phe levels over the past 12 months will be collected. Demographic information will be asked, as well as questions regarding their current Phe counting system. Patients will be educated on the new counting system, stressing 3 key principles: 1) free use of fruits and vegetables, low in protein, 2) protein counting as a simpler version of Phe counting, including reinforcement of label reading, and 3) daily use of PKU formula for enhanced nutrient and protein intake. Patients will be given written educational tools to reinforce this new method.
At the end of the 12 months, subjects will be asked to provide a 3-day food record, and questions will be asked about their attitudes toward the use of the new simplified system.
Phenylalanine levels from the 12-month study period will be used to compare with historical data.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Nebraska
-
Omaha, Nebraska, United States, 68114
- Children's Hospital & Medical Center
-
Omaha, Nebraska, United States, 68198
- Unversity of Nebraska Medical Center
-
Omaha, Nebraska, United States, 68131
- Nebraska Medicine, Midtown Health Center
-
Omaha, Nebraska, United States, 68106
- Monroe-Meyer Insititute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Positive diagnosis of PKU
- Males and females >13 year of age
- Currently on phenylalanine-restricted diet
Exclusion Criteria:
- Any woman planning, or becoming pregnant during study duration
- Any patient who starts Kuvan during the study, as Kuvan lowers phenylalanine levels in some patients.
- Any patient currently enrolled in other research studies (Prism 301/302 Protocol; Institutional Review Board Protocol # 376-13-FB)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Dietary Protein Counting & Free Fruits & Vegetables
Subjects will be educated on new simplified diet approach and phenylalanine levels will be monitored for 1 year, and will be compared to 12 months prior to study enrollment
|
Subjects will be educated on new simplified diet approach and phenylalanine levels will be monitored for 1 year, and will be compared to 12 months prior to study enrollment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Metabolic Control in Teens and Adults with PKU
Time Frame: 12 months
|
phenylalanine levels
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
attitudes towards simplified diet approach
Time Frame: 12 months
|
qualitative data collection
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jill C Skrabal, PhD, University of Nebraska
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0451-15-EP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Phenylketonuria
-
Vitaflo International, LtdUniversity College London HospitalsRecruiting
-
BioMarin PharmaceuticalRecruitingPhenylketonuria (PKU)United States, Germany, Italy
-
Nutricia ResearchCompleted
-
BioMarin PharmaceuticalActive, not recruiting
-
BioMarin PharmaceuticalCompletedPhenylketonuria (PKU)United States, Turkey, Canada, France, Germany, Italy, United Kingdom
-
Washington University School of MedicineUniversity of Missouri-Columbia; Northwestern University; Oregon Health and Science... and other collaboratorsTerminated
-
BioMarin PharmaceuticalRecruitingPhenylketonuria (PKU)United States
-
University of Southern CaliforniaBioMarin PharmaceuticalCompleted
-
Stanford UniversityBioMarin PharmaceuticalWithdrawnClassical Phenylketonuria(PKU)
-
BioMarin PharmaceuticalActive, not recruitingPhenylketonuria (PKU)United States, Germany
Clinical Trials on Dietary Protein Counting and Free Fruits and Vegetables
-
Baylor Research InstituteCompletedCardiovascular Diseases | Hypertension | Chronic Kidney DiseasesUnited States
-
University of ManitobaDalhousie UniversityRecruitingChronic Kidney Disease | HyperkalemiaCanada
-
The University of Tennessee, KnoxvilleActive, not recruitingObesityUnited States
-
Laval UniversityCompleted
-
Baylor Research InstituteCompleted
-
University of California, San FranciscoAmerican Heart AssociationNot yet recruiting
-
University of CincinnatiCompleted
-
United Arab Emirates UniversityUnknownVisceral ObesityUnited Arab Emirates
-
University of Nebraska LincolnCompletedObesity | OverweightUnited States
-
Texas Tech University Health Sciences CenterCompletedHealth BehaviorUnited States